UBS has maintained a "Buy" rating for Wacker Chemie with a target price of 102 euros, despite mixed financial results. The operating result (EBITDA) exceeded expectations, but free cash flow fell significantly short, leading to anticipated negative price reactions at the market's opening.
UBS has upgraded Wacker Chemie to a 'Buy' rating, setting a price target following a mixed earnings report. While the operating result (EBITDA) exceeded expectations, free cash flow fell significantly short, leading the analyst to anticipate a slight negative reaction in share prices at market open.
UBS has maintained a "Buy" rating for Wacker Chemie, setting a target price of 102 euros. While the company's operating result (EBITDA) exceeded expectations, the free cash flow fell significantly short, leading analysts to anticipate a slight negative price reaction at the market's opening.
UBS has maintained its "Buy" rating for Wacker Chemie, setting a target price of 102 euros. Despite a slightly better operating result (EBITDA), the free cash flow fell significantly short of expectations, leading the analyst to anticipate a negative reaction in the stock price at the market's opening.
UBS has maintained a 'Buy' rating for Wacker Chemie, setting a target price of 102 euros. While the company's EBITDA for the final quarter of 2024 exceeded expectations, free cash flow fell significantly short, leading analysts to anticipate a slight negative market reaction.